Please Wait a Moment
X

Articles

01May

CTS Implements HLA Class I and II Testing on the Gemini

01 May, 2019 | Return|

CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.

 

 

 

 

Related

CTS moving to new sFTP Server

CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...

Read More >

CTS implements Ortho VIP Viral Marker Testing Platform

On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...

Read More >

Reminder- Check flights and cargo hours for the Thanksgiving holiday

As a friendly reminder, airlines often change their routine flights and cargo hours for hol...

Read More >

Renewed licenses now available on the website

As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....

Read More >

Update on CTS Implementation of the Grifols Procleix Ultrio Elite Assay

In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...

Read More >

Reminder- Check flights and cargo hours for the Christmas Day Holiday

As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...

Read More >